全球术后妇科感染治疗市场 – 行业趋势及 2029 年预测

术后妇科感染治疗市场分析及规模

预计全球术后妇科感染治疗市场将在预测期内出现显着增长。术后发生妇科感染的患者最有可能死亡，或在 ICU 病房中长时间暴露，并且更容易再次入院，从而限制了术后妇科感染治疗市场。单切口腹腔镜手术的一些主要优点是感染几率低、恢复快、美容效果更好、术后疼痛更少。COVID-19 也对市场增长产生了重大影响。

Data Bridge Market Research 分析了 2022-2029 年预测期内全球术后妇科感染治疗市场的增长率。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

术后妇科感染治疗市场范围和细分

Market Definition

Postoperative infection is the most common site complication of surgical procedures in gynaecology. The Centres for Disease Control and Prevention (CDC) defined an SSI as a type of infection that occurs within 30 days of an operation in one of three locations that are superficial at the incision site, deep at the incision site, or in other organs or spaces opened or manipulated during an operation.

Global Post Surgical Gynecologic Infection Treatment Market Dynamics

Drivers

• Increased Health Insurance Policies

Rising health insurance in the market is expected to boost the market growth. Minimally invasive laparoscopic surgeries are being covered by numerous health insurance providers in selected countries. For instance, Medicare now covers up to 75% of laparoscopic operations, as listed in the Medicare Benefits Schedule (MBS). These factors have led to patients' increased preference for minimally invasive surgeries. This boosts the market growth.

• Rise in Uterine Cancer

Increase in uterine cancer cases boost the growth of the market. Uterine cancer is one of the most prevalent gynecological disorders worldwide and its incidence is rising at an exponential rate. The increase in obesity cases has commonly driven this upsurge. For instance, as per the American Cancer Society, Inc., about, 66,570 new uterine cancer cases are expected to be diagnosed in 2021. Furthermore, the Canadian Cancer Society projected almost 7,400 women in Canada were estimated to be diagnosed with uterine cancer in 2020. This boosts the market growth.

Opportunities

• Growing Healthcare Infrastructure and Policies

The presence of a large patient pool, a strong presence of key players, ease of drug availability, well-established healthcare infrastructure, favorable reimbursement policies in the healthcare system, rise in R&D, and innovation activities and higher adoption of advanced therapeutics may create opportunities for the market.    

• Increasing Demand for Retail Pharmacies

The rise in the number of drugs for post surgical infection delivered through retail pharmacies and the increase in the number of retail pharmacies in highly developed countries create opportunities for the market growth. In addition to this, patients choose retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

• Lack of Skilled Professionals

Lack of trained professionals who are unaware of the treatment methods for this disease could curb the growth of the global post surgical gynecologic infection treatment market over a forecast period.

• High Cost

The huge expenditure associated with the treatment procedures and medications hampers the market growth.

This global post surgical gynecologic infection treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global post surgical gynecologic infection treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Post Surgical Gynecologic Infection Treatment Market Scope

The global post surgical gynecologic infection treatment market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Superficial Incisional Surgical Infection Vaginal Cuffs Cellulitis
• Deep Incisional Surgical Infection Includes Pelvic Cellulitis
• Organ Surgical Infection Incudes Adnexal Infection and Pelvic Abscesses

Treatment

• Antimicrobials
• Antibiotics

Route of Administration

• Oral
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Global Post Surgical Gynecologic Infection Treatment Market Regional Analysis/Insights

The global post surgical gynecologic infection treatment market is analysed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.

全球术后妇科感染治疗市场报告涉及的主要国家 包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于亚太地区主要仿制药公司的存在以及政府举措和特殊社区的兴起，在整个预测期内，亚太地区全球术后妇科感染治疗市场一直呈现大幅增长。

由于该疾病往往影响女性，且治疗选择众多，因此北美在市场中占据主导地位。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和全球术后妇科感染治疗市场份额分析

全球术后妇科感染治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球术后妇科感染治疗市场的关注有关。

全球术后妇科感染治疗市场的主要参与者包括：

• 强生私人有限公司（美国）
• Mylan NV（美国）
• 太阳制药工业有限公司 (印度)
• 赛诺菲公司（法国）
• 克洛维斯肿瘤学（美国）
• 拜耳公司（德国）
• 礼来（美国）
• 默克公司（美国）
• 葛兰素史克公司 (英国)
• 诺华公司（瑞士）
• AbbVie Inc.（美国）
• Vivesto AB（瑞典）

SKU-55809